Barclays share price has rallied in recent weeks in the hope that COVID-19 vaccines will bring some normality back. Even with fortunes on the up, a recent government report has forced experts to take a bearish view on the bank.

Following what’s been a disastrous year for all banks, Barclays shares enjoyed an upswing in November. The promise of COVID-19 vaccines from Pfizer, Moderna, and others has buoyed markets across the board. The Barclays share price was up 40% by mid-November from 107p to 150p. Interest has since subsided, but shares remained above the November-low at 142p when trading began on 2 December.